News

Article

Pharmaceutical Technology

Pharmaceutical Technology, Bio/Pharma Outsourcing Innovation, February 2023
Volume2023 eBook
Issue 1
Pages: 16-21

Scaling Manufacturing Processes Using Single-Use Technologies

Author(s):

Although new single-use technologies offer the flexibility needed to overcome several challenges in ATMP production, there are many considerations and hurdles manufacturers must be aware of when scaling.

RGtimeline - Stock.adobe.com

RGtimeline - Stock.adobe.com

Since biological drugs first became available, their demand has been increasing—with the biologic market being valued at approximately US$302.63 billion in 2020 and expecting to reach US$509.23 billion by 2026 at a compound annual growth rate of 9.06% (1). With advancements in research and technologies, the diversity of biological drugs available is broad, including monoclonal antibodies (mAbs), prophylactic vaccines, gene therapy viral vectors (mainly lentivirus and adeno-associated virus), cell therapies (e.g., chimeric antigen receptor T-cell therapy and modified stem cells), and oncolytic viruses (e.g., adenoviruses, herpes viruses, and vaccinia virus).

As a result, the bioreactor vendor and contract development and manufacturing organization industries are under pressure to increase production scale. To meet demand, these industries must feasibly scale up while considering safety, manual operator handling, engineering, infrastructure, costs, and finally biological processing itself.

Read this article in Pharmaceutical Technology's February 2023 Bio/Pharma Outsourcing Innovation eBook.

About the author

Kai Lipinski, PhD, is the chief scientific officer of Vibalogics.

Article details

Pharmaceutical Technology
eBook: Bio/Pharma Outsourcing Innovation
February 2023
Pages: 16-21

Citation

When referring to this article, please cite it as Lipinski, K. Scaling Manufacturing Processes Using Single-Use Technologies. Pharmaceutical Technology's Bio/Pharma Outsourcing Innovation eBook (February 2023).

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
 Benjamin McLeod and Sebastian Lykke Skafte Andersen go behind the headlines to examine the motivations behind recent M&A activity, tariff responses, and more.
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com